We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.86%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$23M
(-0.77%)
Cap. Flow
-$69.1M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
27.52%
Holding
462
New
54
Increased
149
Reduced
151
Closed
64
Avg Time Held
1.1
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$51.1M |
| 2 |
AbbVie
ABBV
|
+$36.3M |
| 3 |
Juniper Networks
JNPR
|
+$34.2M |
| 4 |
MSCI
MSCI
|
+$34.2M |
| 5 |
Darden Restaurants
DRI
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$46.5M |
| 2 |
Union Pacific
UNP
|
+$39.8M |
| 3 |
VeriSign
VRSN
|
+$37.8M |
| 4 |
Jack Henry & Associates
JKHY
|
+$36.2M |
| 5 |
Booz Allen Hamilton
BAH
|
+$33.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20% |
| 2 | Healthcare | 19.75% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Industrials | 11.13% |
| 5 | Financials | 10.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DTSI
176
DELISTED
DTS, Inc.
DTSI
| $883K | 0.03% |
28,960
-32,200
| -53% | -$1.08M |
2014 Q2
4 quarters
|
|
|
IMMU
177
DELISTED
Immunomedics Inc
IMMU
| $857K | 0.03% |
211,100
+3,890
| +2% | +$15.9K |
2015 Q1
1 quarter
|
|
|
ALJ
178
DELISTED
Alon USA Energy Inc
ALJ
| $840K | 0.03% |
44,511
+900
| +2% | +$15.3K |
2014 Q4
2 quarters
|
|
|
INFI
179
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $828K | 0.03% |
75,576
-7,740
| -9% | -$99.3K |
2014 Q4
2 quarters
|
|
|
RBCN
180
DELISTED
Rubicon Technology, Inc.
RBCN
| $826K | 0.03% |
34,000
+2,006
| +6% | +$65.5K |
2014 Q4
2 quarters
|
|
181
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $806K | 0.03% |
8,281
+2,245
| +37% | +$214K |
2015 Q1
1 quarter
|
|
|
CTIC
182
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $798K | 0.03% |
+40,915
| New | +$790K |
2015 Q2
0 quarters
|
|
|
NAVG
183
DELISTED
Navigators Group Inc
NAVG
| $713K | 0.02% |
18,386
+400
| +2% | +$15.6K |
2013 Q2
8 quarters
|
|
|
CLVS
184
DELISTED
Clovis Oncology, Inc.
CLVS
| $706K | 0.02% |
+8,081
| New | +$692K |
2015 Q2
0 quarters
|
|
185
Madrigal Pharmaceuticals
MDGL
$10.6B
| $627K | 0.02% |
8,037
+286
| +4% | +$24K |
2014 Q3
3 quarters
|
|
186
Saic
SAIC
$5.59B
| $589K | 0.02% |
11,140
+400
| +4% | +$20.9K |
2015 Q1
1 quarter
|
|
|
CPLA
187
DELISTED
Capella Education Company
CPLA
| $561K | 0.02% |
10,462
-42,170
| -80% | -$2.43M |
2013 Q2
8 quarters
|
|
188
Matrix Service
MTRX
$287M
| $547K | 0.02% |
29,910
+4,010
| +15% | +$78.6K |
2015 Q1
1 quarter
|
|
189
HCI Group
HCI
$2.44B
| $535K | 0.02% |
12,091
-16,160
| -57% | -$725K |
2013 Q3
7 quarters
|
|
190
Rogers Corp
ROG
$2.46B
| $531K | 0.02% |
8,030
+700
| +10% | +$51.8K |
2015 Q1
1 quarter
|
|
|
FRTX
191
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $438K | 0.01% |
198
+18
| +10% | +$56.4K |
2014 Q2
4 quarters
|
|
192
Criteo S.A.
CRTO
$772M
| $272K | 0.01% |
5,708
-1,550
| -21% | -$70.6K |
2014 Q3
3 quarters
|
|
193
Novo Nordisk
NVO
$173B
| $266K | 0.01% |
9,710
-2,660
| -22% | -$74.8K |
2013 Q2
8 quarters
|
|
|
BT
194
DELISTED
BT Group plc (ADR)
BT
| $263K | 0.01% |
7,412
-2,000
| -21% | -$69.9K |
2013 Q2
8 quarters
|
|
195
Grupo Aeroportuario Centro Norte
OMAB
$4.41B
| $258K | 0.01% |
6,575
-1,770
| -21% | -$70.4K |
2013 Q3
7 quarters
|
|
196
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $257K | 0.01% |
5,940
-1,560
| -21% | -$66K |
2013 Q2
8 quarters
|
|
197
Check Point Software Technologies
CHKP
$14.1B
| $251K | 0.01% |
3,151
-880
| -22% | -$74.4K |
2014 Q3
3 quarters
|
|
198
Mizuho Financial
MFG
$123B
| $251K | 0.01% |
57,783
+3,771
| +7% | +$15.1K |
2013 Q3
7 quarters
|
|
|
DEG
199
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $247K | 0.01% |
11,981
-3,220
| -21% | -$72.4K |
2014 Q4
2 quarters
|
|
200
Ryanair
RYAAY
$27B
| $239K | 0.01% |
8,166
-4,119
| -34% | -$114K |
2014 Q3
3 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Smith Group Asset Management held 462 positions worth $2.97B, down 0.77% from $2.99B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Smith Group Asset Management's Q2 2015 filing shows 54 new, 149 increased, 151 reduced and 64 closed positions. Its largest new stake was Juniper Networks: 1,304,200 shares worth $33.9M. The largest sale was Celgene Corp, an estimated $46.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Smith Group Asset Management's largest Q2 2015 buy was Juniper Networks: 1,304,200 shares worth $33.9M.
- Smith Group Asset Management added most to General Dynamics in Q2 2015, an estimated $51.1M increase.
- Smith Group Asset Management's biggest Q2 2015 reduction was Intercontinental Exchange, cutting an estimated $28.9M.
- Smith Group Asset Management fully exited Celgene Corp in Q2 2015, selling an estimated $46.5M.
- Smith Group Asset Management's ten largest holdings make up 28% of its $2.97B portfolio in Q2 2015.
- Smith Group Asset Management opened 54 new positions and closed 64 in Q2 2015.
- Smith Group Asset Management's portfolio value fell 0.77% quarter-over-quarter to $2.97B.
Based on Smith Group Asset Management's 13F filing for Q2 2015, filed 29 Jul 2015.